Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
CombiMatrix announces human drug metabolism array
August 6th, 2004
Acacia Research Corp.'s (CBMX) CombiMatrix group has made available to researchers a new CustomArray Human Drug Metabolism Array. This array enables researchers to screen a panel of genes and "splice variants" known to be critical for the pharmokinetics and metabolism for both established and new drugs. "This catalog array, for drug metabolism, is the first in a series of catalog arrays which we will be releasing over the coming months," stated Dr. Amit Kumar, president and CEO of CombiMatrix. "We have recently launched our low density and high density arrays, and our catalog array initiative is intended to provide customers with predesigned arrays...
Source: Genomics & Genetics Weekly (2004-08-06)
|
